These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37453238)

  • 21. Role of drug metabolism in drug discovery and development.
    Kumar GN; Surapaneni S
    Med Res Rev; 2001 Sep; 21(5):397-411. PubMed ID: 11579440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. From toxic precursors to safe drugs. Mechanisms and relevance of idiosyncratic drug reactions.
    Petersen KU
    Arzneimittelforschung; 2002; 52(6):423-9. PubMed ID: 12109041
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Opportunities for Accelerating Drug Discovery and Development by Using Engineered Drug-Metabolizing Enzymes.
    Gillam EMJ; Kramlinger VM
    Drug Metab Dispos; 2023 Mar; 51(3):392-402. PubMed ID: 36460479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of reactive metabolites in natural products-driven drug discovery.
    Njuguna NM; Masimirembwa C; Chibale K
    J Nat Prod; 2012 Mar; 75(3):507-13. PubMed ID: 22296642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of biotransformation studies in minimizing metabolism-related liabilities in drug discovery.
    Shu YZ; Johnson BM; Yang TJ
    AAPS J; 2008; 10(1):178-92. PubMed ID: 18446518
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug metabolites as cytochrome p450 inhibitors: a retrospective analysis and proposed algorithm for evaluation of the pharmacokinetic interaction potential of metabolites in drug discovery and development.
    Callegari E; Kalgutkar AS; Leung L; Obach RS; Plowchalk DR; Tse S
    Drug Metab Dispos; 2013 Dec; 41(12):2047-55. PubMed ID: 23792812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic stability and its role in the discovery of new chemical entities.
    Słoczyńska K; Gunia-Krzyżak A; Koczurkiewicz P; Wójcik-Pszczoła K; Żelaszczyk D; Popiół J; Pękala E
    Acta Pharm; 2019 Sep; 69(3):345-361. PubMed ID: 31259741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of biotransformation in drug-induced toxicity: influence of intra- and inter-species differences in drug metabolism.
    Baillie TA; Rettie AE
    Drug Metab Pharmacokinet; 2011; 26(1):15-29. PubMed ID: 20978360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Method for rapid metabolite profiling of drug candidates in fresh hepatocytes using liquid chromatography coupled with a hybrid quadrupole linear ion trap.
    Gao H; Materne OL; Howe DL; Brummel CL
    Rapid Commun Mass Spectrom; 2007; 21(22):3683-93. PubMed ID: 17937450
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cunninghamella Biotransformation--Similarities to Human Drug Metabolism and Its Relevance for the Drug Discovery Process.
    Piska K; Żelaszczyk D; Jamrozik M; Kubowicz-Kwaśny P; Pękala E
    Curr Drug Metab; 2016; 17(2):107-17. PubMed ID: 26526834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of pharmacologically active metabolites in drug discovery and development.
    Fura A
    Drug Discov Today; 2006 Feb; 11(3-4):133-42. PubMed ID: 16533711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclic metabolites: chemical and biological considerations.
    Erve JC
    Curr Drug Metab; 2008 Feb; 9(2):175-88. PubMed ID: 18288959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting reactive drug metabolites for reducing the potential for drug toxicity.
    Grillo MP
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1281-302. PubMed ID: 26005795
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The early estimation of circulating drug metabolites in humans.
    Luffer-Atlas D
    Expert Opin Drug Metab Toxicol; 2012 Aug; 8(8):985-97. PubMed ID: 22681256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo metabolite detection and identification in drug discovery via LC-MS/MS with data-dependent scanning and postacquisition data mining.
    Triolo A; Altamura M; Dimoulas T; Guidi A; Lecci A; Tramontana M
    J Mass Spectrom; 2005 Dec; 40(12):1572-82. PubMed ID: 16320289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid chromatography-mass spectrometry in in vitro drug metabolite screening.
    Tolonen A; Turpeinen M; Pelkonen O
    Drug Discov Today; 2009 Feb; 14(3-4):120-33. PubMed ID: 19059358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of quantitative NMR in pharmacological evaluation of biologically generated metabolites: implications in drug discovery.
    Mutlib A; Espina R; Vishwanathan K; Babalola K; Chen Z; Dehnhardt C; Venkatesan A; Mansour T; Chaudhary I; Talaat R; Scatina J
    Drug Metab Dispos; 2011 Jan; 39(1):106-16. PubMed ID: 20952552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metatox - Web application for generation of metabolic pathways and toxicity estimation.
    Rudik A; Bezhentsev V; Dmitriev A; Lagunin A; Filimonov D; Poroikov V
    J Bioinform Comput Biol; 2019 Feb; 17(1):1940001. PubMed ID: 30866738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A perspective on the contribution of metabolites to drug-drug interaction potential: the need to consider both circulating levels and inhibition potency.
    Yu H; Tweedie D
    Drug Metab Dispos; 2013 Mar; 41(3):536-40. PubMed ID: 23143892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Liquid chromatography coupled to mass spectrometry for metabolite profiling in the field of drug discovery.
    Saurina J; Sentellas S
    Expert Opin Drug Discov; 2019 May; 14(5):469-483. PubMed ID: 30810397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.